(Q36824013)

English

Ki-67 is an independent predictor of metastasis and cause-specific mortality for prostate cancer patients treated on Radiation Therapy Oncology Group (RTOG) 94-08.

scientific article published on 6 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Ki-67 is an independent predictor of metastasis and cause-specific mortality for prostate cancer patients treated on Radiation Therapy Oncology Group (RTOG) 94-08. (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Adaptive radiation therapy

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Bret Verhoven

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Yan Yan

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Mark Ritter

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Li-Yan Khor

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Elizabeth Hammond

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Christopher Jones

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Mahul Amin

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Jean-Paul Bahary

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Kenneth Zeitzer

9

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Alan Pollack

10

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

language of work or name

0 references

publication date

6 March 2013

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

86

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

317-323

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Predictive models in external beam radiotherapy for clinically localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646974

29 September 2017

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646974

29 September 2017

COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646974

29 September 2017

Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646974

29 September 2017

Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646974

29 September 2017

Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646974

29 September 2017

Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646974

29 September 2017

Radiotherapy and short-term androgen deprivation for localized prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646974

5 September 2018

Comparative analysis of four histopathological classification systems to discriminate benign and malignant behaviour in gastrointestinal stromal tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646974

5 September 2018

Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: an analysis of patients in radiation therapy oncology group protocol 86-10.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646974

5 September 2018

Tumor cell proliferation and survival in patients with prostate cancer followed expectantly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3646974

5 September 2018

Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23474109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23474109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

1 reference

https://pubmed.ncbi.nlm.nih.gov/23474109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.IJROBP.2013.01.016

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

release_iic6zwjznjefxaar6yrdz2uayq

1 reference

https://api.fatcat.wiki/v0/release/iic6zwjznjefxaar6yrdz2uayq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36824013&oldid=1838671534"